The move comes as the global biotech and biopharma CDMO market continues to surge, fueled by rising demand
This production block consists of chemical synthesis reactions and clean rooms areas to produce final API
Natural Capsules Limited's shareholding will be reduced to 89.99%
The proceeds from this fund-raise will be deployed in financing the project requirements of the API business
Against targeted investment of Rs. 3,938 crore, investments worth Rs. 4,024 crores have been made under scheme
Indian government is expecting pharmaceutical industry to fetch incremental sales worth Rs. 294,000 crore and exports up to Rs. 196,000 crore by FY 2027-28
Subscribe To Our Newsletter & Stay Updated
